Search
STERIS plc
STEAdd to Watchlist
234.930USD
+4.590+1.99%
Close 07-29 16:00（ET）Quotes delayed by 15 min
23.05BMarket Cap
29.49P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-29The current earnings forecast score of STERIS plc is 7.64, ranking 131 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 293.00, with a high of 300.00 and a low of 231.81.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
264.654
Target Price
+21.18%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
STERIS plc
STE
11
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
31
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
31
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is STERIS plc's expected revenue for the next quarter?
STERIS plc's expected revenue is 1.50B.
What is STERIS plc's price target?
Analysts forecast that STERIS plc's price target is USD 293.00, with the highest forecast at USD 300.00 and the lowest forecast at USD 231.81.
How have STERIS plcSTE's recent earnings per share performed?
The market expectation was USD 2.25, while STERIS plcSTE's earnings per share (EPS) for the previous quarter was USD 1.96. EPS for the next quarter is expected at USD 2.50.
What is the analyst rating for STERIS plc?
Based on the ratings of STERIS plc's stock from 11 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.